HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Philip J Mease Selected Research

Fibromyalgia (Fibrositis)

6/2014Effects of milnacipran on the multidimensional aspects of fatigue and the relationship of fatigue to pain and function: pooled analysis of 3 fibromyalgia trials.
1/2014Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a randomized, double-blind, placebo-controlled withdrawal study.
6/2013Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin.
1/2013Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial.
6/2011Estimation of minimum clinically important difference for pain in fibromyalgia.
4/2011Pharmacotherapy of fibromyalgia.
3/2011Evaluation of duloxetine for chronic pain conditions.
2/2011Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data.
7/2010Pain response profile of patients with fibromyalgia treated with duloxetine.
6/2010Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Philip J Mease Research Topics

Disease

45Psoriatic Arthritis
11/2015 - 04/2002
23Psoriasis (Pustulosis Palmaris et Plantaris)
12/2015 - 07/2004
21Fibromyalgia (Fibrositis)
06/2014 - 04/2005
20Pain (Aches)
06/2015 - 04/2005
19Rheumatoid Arthritis
05/2014 - 07/2004
10Arthritis (Polyarthritis)
06/2014 - 05/2002
7Fatigue
06/2014 - 04/2005
6Ankylosing Spondylitis
03/2015 - 03/2007
5Inflammation
06/2013 - 04/2002
4Skin Manifestations
06/2015 - 10/2005
4Necrosis
11/2014 - 01/2013
4Disease Progression
03/2014 - 07/2004
4Infection
12/2011 - 05/2007
3Nausea
06/2013 - 02/2009
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2008 - 09/2004
2Skin Diseases
06/2015 - 05/2011
2Autoimmune Diseases (Autoimmune Disease)
03/2015 - 07/2008
2Joint Diseases (Joint Disease)
11/2014 - 03/2007
2Dizziness (Lightheadedness)
06/2013 - 09/2009
2Constipation
06/2013 - 09/2009
2Histoplasmosis
04/2010 - 07/2009
2Headache (Headaches)
09/2009 - 02/2009
1Knee Osteoarthritis
05/2014
1Congenital Abnormalities (Deformity)
03/2014
1Spondylitis
08/2013
1Back Pain (Backache)
06/2013
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
04/2011
1Neuralgia (Stump Neuralgia)
03/2011
1Low Back Pain (Lumbago)
03/2011
1Osteoarthritis
03/2011
1Myocardial Infarction
02/2011
1Heart Failure
02/2011
1Stroke (Strokes)
02/2011
1Melanoma (Melanoma, Malignant)
11/2010
1Skin Neoplasms (Skin Cancer)
11/2010
1Infectious Arthritis (Septic Arthritis)
04/2010
1Disease Susceptibility (Diathesis)
02/2010
1Diarrhea
09/2009
1Sleep Initiation and Maintenance Disorders (Insomnia)
09/2009

Drug/Important Bio-Agent (IBA)

13adalimumab (Humira)FDA Link
06/2015 - 07/2005
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2010 - 04/2002
10Biological Markers (Surrogate Marker)IBA
06/2014 - 08/2009
9milnacipran (Ixel)FDA Link
06/2014 - 10/2005
9duloxetine (Cymbalta)FDA Link
06/2011 - 06/2008
8TNFR-Fc fusion protein (etanercept)FDA Link
03/2014 - 04/2002
7Antirheumatic Agents (DMARD)IBA
06/2014 - 07/2004
7Methotrexate (Mexate)FDA LinkGeneric
03/2014 - 05/2006
7rituximab (Mabthera)FDA Link
05/2013 - 01/2008
6Norepinephrine (Noradrenaline)FDA LinkGeneric
08/2011 - 02/2009
6Serotonin (5 Hydroxytryptamine)IBA
08/2011 - 02/2009
5Interleukin-17 (Interleukin 27)IBA
10/2015 - 03/2014
5ametantrone (HAQ)IBA
06/2015 - 01/2008
5pregabalin (Lyrica)FDA Link
06/2013 - 04/2005
4C-Reactive ProteinIBA
06/2015 - 03/2007
3CytokinesIBA
11/2015 - 04/2002
3Prostaglandins A (PGA)IBA
06/2015 - 05/2011
3apremilastIBA
03/2015 - 03/2014
3icodextrin (Extraneal)FDA Link
05/2013 - 02/2007
3Dehydroepiandrosterone (DHEA)IBA
08/2008 - 09/2004
2Proteins (Proteins, Gene)IBA
11/2015 - 01/2013
2Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
03/2015 - 06/2014
2infliximab (Remicade)FDA Link
03/2014 - 07/2005
2Rheumatoid FactorIBA
03/2014 - 05/2007
2golimumabFDA Link
11/2013 - 01/2013
2Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
08/2011 - 12/2009
2CDP870FDA Link
06/2011 - 02/2011
2Neurotransmitter Agents (Neurotransmitter)IBA
04/2011 - 12/2009
2Carbon MonoxideIBA
04/2011 - 06/2008
2alefacept (Amevive)FDA Link
03/2009 - 05/2006
2GlucocorticoidsIBA
08/2008 - 04/2005
2efalizumabFDA Link
03/2007 - 07/2005
1HLA-C Antigens (HLA-C)IBA
12/2015
1Interleukin-23 (Interleukin 23)IBA
03/2015
1monoclonal antibody CNTO 1275 (CNTO 1275)FDA Link
03/2015
1InterleukinsIBA
03/2015
1Interleukin-12 (IL 12)IBA
03/2015
1Interleukin-17 ReceptorsIBA
06/2014
1Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2014
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2013
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2013
1Apolipoprotein C-IIIIBA
01/2013
1AdiponectinIBA
01/2013
1Opioid Analgesics (Opioids)IBA
08/2011
1Anticonvulsants (Antiepileptic Drugs)IBA
08/2011
1Analgesics (Analgesic Drugs)IBA
08/2011
1Amitriptyline (Elavil)FDA LinkGeneric
02/2011
1venlafaxine (Effexor)FDA LinkGeneric
02/2011
1leflunomide (Arava)FDA LinkGeneric
04/2010
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
04/2010
1Immunoglobulin G (IgG)IBA
04/2010
1Deoxyribonucleases (DNase)IBA
04/2010
1dichlorodifluoromethane (FC 12)IBA
04/2010
1Immunoglobulins (Immunoglobulin)IBA
04/2010

Therapy/Procedure

7Drug Therapy (Chemotherapy)
11/2014 - 03/2007
3Biological Therapy
11/2015 - 11/2005
2Retreatment
12/2011 - 05/2010
2Therapeutics
09/2011 - 05/2003
1Aftercare (After-Treatment)
01/2014
1Subcutaneous Injections
11/2013
1Immunomodulation
11/2010